Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion - a Prospective, Open Label, Single Center Study With 12 Months of Follow-up.
Latest Information Update: 23 Aug 2023
At a glance
- Drugs FPF 1070 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 23 Aug 2022 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 23 Aug 2022 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.
- 01 Jun 2021 New trial record